Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Alcon acquires Neurotech and its approved Encelto for $550M
Alcon says it will now help take Encelto global and leverage Neurotech's technology to develop more convenient ocular therapies.
Donavyn Coffey
Oct 21, 2026 10:56am
ICER, West Health call out excessive U.S. drug launch prices
Oct 21, 2026 10:36am
Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue
Brought to you by
Bain & Company
CSL taps GSK’s Deborah Waterhouse as CEO in darkest hour
Oct 21, 2026 10:22am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
GSK wins groundbreaking FDA green light in chronic hepatitis B
Oct 21, 2026 6:39am
